Gulyás B - Search Results

1

Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.

Takano A, Gulyás B, Varrone A, Karlsson P, Schou M, Airaksinen AJ, Vandenhende F, Tauscher J, Halldin C. Takano A, et al. Among authors: gulyas b. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):153-7. doi: 10.1007/s00259-007-0598-8. Epub 2007 Oct 2. Eur J Nucl Med Mol Imaging. 2008. PMID: 17909794 Clinical Trial.

2

Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.

Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Vas A, Kiss B, Kárpáti E, Farde L. Gulyás B, et al. Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1031-8. doi: 10.1007/s00259-002-0823-4. Epub 2002 May 7. Eur J Nucl Med Mol Imaging. 2002. PMID: 12173017 Clinical Trial.

3

Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.

Gulyás B, Vas A, Halldin C, Sóvágó J, Sandell J, Olsson H, Fredriksson A, Stone-Elander S, Farde L. Gulyás B, et al. Nucl Med Biol. 2002 Oct;29(7):753-9. doi: 10.1016/s0969-8051(02)00319-0. Nucl Med Biol. 2002. PMID: 12381455

4

[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].

Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B. Vas A, et al. Among authors: gulyas b. Orv Hetil. 2002 Nov 24;143(47):2631-6. Orv Hetil. 2002. PMID: 12532649 Hungarian.

5

Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.

Schou M, Halldin C, Sóvágó J, Pike VW, Gulyás B, Mozley PD, Johnson DP, Hall H, Innis RB, Farde L. Schou M, et al. Among authors: gulyas b. Nucl Med Biol. 2003 Oct;30(7):707-14. doi: 10.1016/s0969-8051(03)00079-9. Nucl Med Biol. 2003. PMID: 14499328

6

[Human positron emission tomography with oral 11C-vinpocetine].

Vas A, Christer H, Sóvágó J, Johan S, Cselényi Z, Kiss B, Kárpáti E, Lars F, Gulyás B. Vas A, et al. Among authors: gulyas b. Orv Hetil. 2003 Nov 16;144(46):2271-6. Orv Hetil. 2003. PMID: 14702922 Clinical Trial. Hungarian.

7

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.

Schou M, Halldin C, Sóvágó J, Pike VW, Hall H, Gulyás B, Mozley PD, Dobson D, Shchukin E, Innis RB, Farde L. Schou M, et al. Among authors: gulyas b. Synapse. 2004 Aug;53(2):57-67. doi: 10.1002/syn.20031. Synapse. 2004. PMID: 15170818

8

Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.

Sóvágó J, Farde L, Halldin C, Langer O, Laszlovszky I, Kiss B, Gulyás B. Sóvágó J, et al. Among authors: gulyas b. Neurochem Int. 2004 Oct;45(5):609-17. doi: 10.1016/j.neuint.2004.04.004. Neurochem Int. 2004. PMID: 15234102

9

Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data.

Cselényi Z, Lundberg J, Halldin C, Farde L, Gulyás B. Cselényi Z, et al. Among authors: gulyas b. Neurochem Int. 2004 Oct;45(5):773-81. doi: 10.1016/j.neuint.2003.12.005. Neurochem Int. 2004. PMID: 15234122

10

N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.

Marchais-Oberwinkler S, Nowicki B, Pike VW, Halldin C, Sandell J, Chou YH, Gulyas B, Brennum LT, Farde L, Wikström HV. Marchais-Oberwinkler S, et al. Among authors: gulyas b. Bioorg Med Chem. 2005 Feb 1;13(3):883-93. doi: 10.1016/j.bmc.2004.10.033. Bioorg Med Chem. 2005. PMID: 15653354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page